CHEK

Stats

Summary

check-cap is a clinical stage medical diagnostics company leading the development of the first ingestible imaging capsule that utilizes low-dose x-rays for crc screening. the check-cap device requires no bowel preparation or invasive procedures, and is designed to detect clinically significant polyps with a high degree of sensitivity. check-cap's advanced technology has been proven in animals, and is designed to offer several advantages compared to current screening procedures. founded in early 2005, check-cap recruited a team of world-class experts in physics, software engineering, electronics, mechanics and physiology, who have been developing a multi-disciplinary imaging solution for imaging and screening of the colon. the system includes a capsule, a receiver, proprietary imaging software and an associated database for web based access and analysis. check-cap's advanced technology has been proven in animals and promises to offer several significant advantages compared to other colo

Market Cap: 11.1 Million

Primary Exchange: NASDAQ

Website: http://www.check-cap.com

Shares Outstanding: 5.85 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 0.7201425678365649

Sector: Manufacturing

Industry: Irradiation Apparatus Manufacturing

Ethical Flags

Longest drawdown: 1963 trading days

From: 2018-04-24 To: 2024-03-07

Lowest Point:

Ex-Date	Payment Date	Record Date	Declared Date	Amount	Flag	Dividend Type	Qualified	Indicated

Ex-Date	Declared Date	Record Date	Payment Date	Ratio	To Factor	For Factor